JNCE

Jounce Therapeutics, Inc. Common Stock
JNCE

Overview Fund Activity
Delisted

JNCE was delisted on the 3rd of May, 2023.

Back to rankings

84 hedge funds and large institutions have $64.1M invested in Jounce Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
-1
Holders Change %
-1.18%
% of All Funds
1.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
21
Reduced
20
Closed
21
Calls
$136K
Puts
$10K
Net Calls
+$126K
Net Calls Change
+$123K

Top Buyers

1
TCM
1
Tang Capital Management
California
$9.81M
2
Tudor Investment Corp
2
Tudor Investment Corp
Connecticut
$5.85M
3
OM
3
Opaleye Management
Massachusetts
$5.33M
4
BCM
4
BML Capital Management
Indiana
$2.01M
5
ACM
5
Ardent Capital Management
Ohio
$1.71M

Top Sellers

1
Bank of America
1
Bank of America
North Carolina
$69.4K
2
RI
2
RTW Investments
New York
$0
3
CAC
3
Cowen and Company
New York
$0
4
Morgan Stanley
4
Morgan Stanley
New York
$222K
5
Millennium Management
5
Millennium Management
New York
$925K
Name Holding Trade Value Shares
Change 		Shares
Change %
Ohio Public Employees Retirement System (OPERS)
101
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$5K -4,882 Closed
Allspring Global Investments
102
Allspring Global Investments
North Carolina
– -$835 -753 Closed
Carson Wealth (CWM LLC)
103
Carson Wealth (CWM LLC)
Nebraska
– -$1K -750 Closed
Citigroup
104
Citigroup
New York
– -$472 -425 Closed
CS
105
Credit Suisse
Switzerland
– -$2 -2 Closed
1 2 3 4
5